Gillian Bonvicini (2023)
Harnessing the molecular Trojan horse: Evaluating properties of preclinical Aβ immunoPET radioligands for optimized brain delivery via the transferrin receptor.

Eva Schlein (2023)
One-click away from higher contrast: Improvements to peripheral clearance for same-day immunoPET in Alzheimer’s disease.

Mengfei Xiong (2023)
Visualising neurodegeneration in the living brain: Preclinical evaluation of PET radioligands.

Rebecca Faresjö Melander (2023)
Factors influencing transferrin receptor-mediated brain delivery: Evaluating preclinical antibody-based proteins for PET imaging in Alzheimer’s disease.

Emma Brolin (2022)
Pathophysiological effects of alpha-synuclein on SNARE complex proteins in models of alpha-synucleinopathies

Anish Behere (2022)
Ex‘PLA’ining the progression of pathological proteins in Alzheimer’s and Parkinson’s diseases: see(d)ing is believing.

Evangelos Konstantinidis (2022)
CRISPR/Cas9-based therapies and the role of astrocytes in Alzheimer’s disease and Parkinson’s disease.

Tobias Gustavsson (2022)
Brain distribution of a bispecific antibody targeting Aβ.

María Pagnon de la Vega (2021)
Characterization of the novel “Uppsala mutation” causing a familial form of early onset Alzheimer’s disease.

Silvio R. Meier (2021)
Preclinical PET imaging and therapy of Alzheimer's disease.

Jinar Rostami (2020)
The role of glial cells in alpha-synuclein pathology: Focus on degradation, cell-to-cell propagation and inflammation.

Leire Almandoz Gil (2018)
Characterization of Physiological and Pathological Alpha-Synuclein: Implications for Parkinson’s Disease and Related Disorders.

Elisabeth Nikitidou (2018)
Cellular responses to amyloid-beta protofibrils: Focus on astrocytes, extracellular vesicles and antibody treatment.

Xiaotian T. Fang (2018)
Preclinical PET imaging of Alzheimer's disease progression.

Gabriel Gustafsson (2017)
Alpha-Synuclein Oligomers: Cellular Mechanisms and Aspects of Antibody Treatment.

Sofia Söllvander (2015)
Amyloid-β Protofibrils in Alzheimer´s Disease: Focus on Antibodies, Inflammation and Astrocytes.

Astrid Gumucio (2014)
Therapeutic and functional studies in animal models of Alzheimer's disease.

Therese Fagerqvist (2013)
Studies of α-synuclein Oligomers-with Relevance to Lewy Body Disorders.

Thomas Näsström (2011)
Characterization of α-synuclein oligomers: Implications for Lewy Body Disorders.

Paul O'Callaghan (2011)
Heparan Sulfate in the Amyloidosis and Inflammation of Alzheimer’s Disease.

Dag Sehlin (2010)
Aß Conformation Dependent Antibodies and Alzheimer's Disease.

Ola Philipson (2010)
Modeling Amyloid-ß Pathology in Alzheimer's Disease Using the Arctic Mutation.

Hillevi Englund (2009)
Soluble amyloid-ß aggregates in Alzheimer's disease.

Anna Lord (2009)
Targeting Early Stages of Alzheimer's Disease in a Transgenic Model.

Lena Skoglund (2009)
Molecular Mechanisms of Frontotemporal Lobar Degeneration.

Elin Blom (2008)
Genetic Studies of Alzheimer's Disease.

Ann-Sofi Johansson (2007)
Amyloid beta Protofibril Formation and Neurotoxicity: Implications for Alzheimer's Disease.

Charlotte Sahlin (2007)
Pathogenic Mechanisms of the Arctic Alzheimer Mutation.

Senast uppdaterad: 2023-11-21